Bank of America Corp DE Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Bank of America acquired 2.92 million DENTSPLY SIRONA shares during the second quarter, valued at approximately $31 million and representing a 1.47% stake.
• Institutional ownership remains high at 95.7%, with several other investors also increasing their positions or initiating new stakes.
• Analysts maintain a consensus “Hold” rating with a $13.31 target price, while XRAY recently traded at $9.95; the company beat quarterly earnings estimates but reported a 4.1% year-over-year revenue decline.

Bank of America Corp DE purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,921,845 shares of the medical instruments supplier's stock, valued at approximately $31,001,000. Bank of America Corp DE owned approximately 1.47% of DENTSPLY SIRONA as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently modified their holdings of the company. Eurizon Capital SGR S.p.A. purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Performa Ltd US LLC increased its stake in shares of DENTSPLY SIRONA by 116.1% during the fourth quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier's stock valued at $49,000 after buying an additional 2,283 shares during the period. Huntington National Bank raised its holdings in shares of DENTSPLY SIRONA by 68.3% in the fourth quarter. Huntington National Bank now owns 4,689 shares of the medical instruments supplier's stock valued at $54,000 after acquiring an additional 1,903 shares in the last quarter. Allworth Financial LP purchased a new stake in DENTSPLY SIRONA in the second quarter worth about $51,000. Finally, Hantz Financial Services Inc. lifted its stake in DENTSPLY SIRONA by 275.0% in the fourth quarter. Hantz Financial Services Inc. now owns 5,992 shares of the medical instruments supplier's stock worth $68,000 after acquiring an additional 4,394 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

Analyst Ratings Changes

A number of research firms have commented on XRAY. Barclays raised their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an "underweight" rating in a research report on Monday, August 24th. Piper Sandler increased their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a "neutral" rating in a research note on Wednesday, July 29th. BMO Capital Markets cut their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a report on Thursday, September 17th. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 10th. Finally, Weiss Ratings restated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $13.31.

DENTSPLY SIRONA Trading Up 5.4%

NASDAQ XRAY opened at $9.95 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The firm has a market cap of $1.98 billion, a PE ratio of -3.62, a price-to-earnings-growth ratio of 1.20 and a beta of 0.84. The company has a 50 day moving average price of $11.78 and a 200 day moving average price of $11.42. DENTSPLY SIRONA Inc. has a 52 week low of $9.36 and a 52 week high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same period last year, the firm earned $0.52 earnings per share. DENTSPLY SIRONA's revenue was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.